Global Lower GI Series Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Lower GI Series Revenue
• 1.4 Market by Type
  • 1.4.1 Global Lower GI Series Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Double-Contrast
  • 1.4.3 Single-Contrast
• 1.5 Market by Application
  • 1.5.1 Global Lower GI Series Market Share by Application: 2020 VS 2026
  • 1.5.2 Gastroenteritis
  • 1.5.3 Colon Polyps
  • 1.5.4 Tumor
  • 1.5.5 Strictures Crohn's Disease
  • 1.5.6 Ulcerative Colitis
  • 1.5.7 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Lower GI Series Market Perspective (2015-2026)
• 2.2 Global Lower GI Series Growth Trends by Regions
  • 2.2.1 Lower GI Series Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lower GI Series Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lower GI Series Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Lower GI Series Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Lower GI Series Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Lower GI Series Players by Market Size
  • 3.1.1 Global Top Lower GI Series Players by Revenue (2015-2020)
  • 3.1.2 Global Lower GI Series Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Lower GI Series Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Lower GI Series Market Concentration Ratio
  • 3.2.1 Global Lower GI Series Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Lower GI Series Revenue in 2019
• 3.3 Lower GI Series Key Players Head office and Area Served
• 3.4 Key Players Lower GI Series Product Solution and Service
• 3.5 Date of Enter into Lower GI Series Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Lower GI Series Historic Market Size by Type (2015-2020)
• 4.2 Global Lower GI Series Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Lower GI Series Market Size by Application (2015-2020)
• 5.2 Global Lower GI Series Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lower GI Series Market Size (2015-2020)
• 6.2 Lower GI Series Key Players in North America (2019-2020)
• 6.3 North America Lower GI Series Market Size by Type (2015-2020)
• 6.4 North America Lower GI Series Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Lower GI Series Market Size (2015-2020)
• 7.2 Lower GI Series Key Players in Europe (2019-2020)
• 7.3 Europe Lower GI Series Market Size by Type (2015-2020)
• 7.4 Europe Lower GI Series Market Size by Application (2015-2020)

8 China

• 8.1 China Lower GI Series Market Size (2015-2020)
• 8.2 Lower GI Series Key Players in China (2019-2020)
• 8.3 China Lower GI Series Market Size by Type (2015-2020)
• 8.4 China Lower GI Series Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Lower GI Series Market Size (2015-2020)
• 9.2 Lower GI Series Key Players in Japan (2019-2020)
• 9.3 Japan Lower GI Series Market Size by Type (2015-2020)
• 9.4 Japan Lower GI Series Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Lower GI Series Market Size (2015-2020)
• 10.2 Lower GI Series Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Lower GI Series Market Size by Type (2015-2020)
• 10.4 Southeast Asia Lower GI Series Market Size by Application (2015-2020)

11 India

• 11.1 India Lower GI Series Market Size (2015-2020)
• 11.2 Lower GI Series Key Players in India (2019-2020)
• 11.3 India Lower GI Series Market Size by Type (2015-2020)
• 11.4 India Lower GI Series Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Lower GI Series Market Size (2015-2020)
• 12.2 Lower GI Series Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Lower GI Series Market Size by Type (2015-2020)
• 12.4 Central & South America Lower GI Series Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Eisai
  • 13.1.1 Eisai Company Details
  • 13.1.2 Eisai Business Overview
  • 13.1.3 Eisai Lower GI Series Introduction
  • 13.1.4 Eisai Revenue in Lower GI Series Business (2015-2020))
  • 13.1.5 Eisai Recent Development
• 13.2 Cadila Pharmaceuticals
  • 13.2.1 Cadila Pharmaceuticals Company Details
  • 13.2.2 Cadila Pharmaceuticals Business Overview
  • 13.2.3 Cadila Pharmaceuticals Lower GI Series Introduction
  • 13.2.4 Cadila Pharmaceuticals Revenue in Lower GI Series Business (2015-2020)
  • 13.2.5 Cadila Pharmaceuticals Recent Development
• 13.3 Purdue Pharma
  • 13.3.1 Purdue Pharma Company Details
  • 13.3.2 Purdue Pharma Business Overview
  • 13.3.3 Purdue Pharma Lower GI Series Introduction
  • 13.3.4 Purdue Pharma Revenue in Lower GI Series Business (2015-2020)
  • 13.3.5 Purdue Pharma Recent Development
• 13.4 Peacehealth
  • 13.4.1 Peacehealth Company Details
  • 13.4.2 Peacehealth Business Overview
  • 13.4.3 Peacehealth Lower GI Series Introduction
  • 13.4.4 Peacehealth Revenue in Lower GI Series Business (2015-2020)
  • 13.4.5 Peacehealth Recent Development
• 13.5 Novadaq
  • 13.5.1 Novadaq Company Details
  • 13.5.2 Novadaq Business Overview
  • 13.5.3 Novadaq Lower GI Series Introduction
  • 13.5.4 Novadaq Revenue in Lower GI Series Business (2015-2020)
  • 13.5.5 Novadaq Recent Development
• 13.6 Astrazeneca
  • 13.6.1 Astrazeneca Company Details
  • 13.6.2 Astrazeneca Business Overview
  • 13.6.3 Astrazeneca Lower GI Series Introduction
  • 13.6.4 Astrazeneca Revenue in Lower GI Series Business (2015-2020)
  • 13.6.5 Astrazeneca Recent Development
• 13.7 Ironwood Pharmaceuticals
  • 13.7.1 Ironwood Pharmaceuticals Company Details
  • 13.7.2 Ironwood Pharmaceuticals Business Overview
  • 13.7.3 Ironwood Pharmaceuticals Lower GI Series Introduction
  • 13.7.4 Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2015-2020)
  • 13.7.5 Ironwood Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer